<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7765853/table_7" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 7</label>
  <p>In vitro anticancer activity of 
   <i>Origanum vulgare</i> L. essential oil (OEO). 
  </p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Details: Source, Phytochemical Composition; Dose, Formulation</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Cancer Cell Line</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Cell Proliferation, Apoptosis, Cytotoxicity, Dose, Incubation Time, Effect</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Reference</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Origanum vulgare</i> L. was harvested from Chile. 
    <br/>GS-MS assay of the OEO showed that 4-terpineol 41.17% was the major component, followed by thymol (21.95%), c-terpinene (5.91%), and carvacrol (4.71%). 
    <br/>Cancerous cells were treated with the OEO ranging from 10 to 500 mg/mL. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">human breast adenocarcinoma (MCF-7) 
    <br/>human colon adenocarcinoma (HT-29) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">The cytotoxicity test was performed by sulforhodamine B assay. 
    <br/>Cancer cells were incubated for 72 h with OEO. 
    <br/>The most effective concentration for HT-29(human colon adenocarcinoma) and MCF-7 (human breast adenocarcinoma) was 50 mg/mL and cell growth inhibition was 60.8% and 48.9%, respectively. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B71-ijms-21-09653" ref-type="bibr">71</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Origanum vulgare</i> L. was collected from Basilicata Region, Southern Italy. 
    <br/>According to GS-MS and GS-FID, thymol and carvacrol were the main phytocompounds (74.8%), followed by citral (2.5%). 
    <br/>Tested concentrations ranged from 100 to 800 µg/µL. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">hepatocarcinoma cell line (HepG2) 
    <br/>non-tumour cell line (HEK293) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">The cytotoxicity test was performed by MTT assay. 
    <br/>They also analysed the cell morphology using phase-contrast microscopy. 
    <br/>Cancer cells were incubated for 24 h with OEO 
    <br/>IC 
    <sub>50</sub> = 236 µg/µL for HepG2 cells 
    <br/>IC 
    <sub>50</sub> = 310 µg/µL for HEK293 cells 
    <br/>HepG2 cells treated with OEO (236 µg/µL, for 24 h) showed morphological changes, such as detaching in the degradation phase. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B70-ijms-21-09653" ref-type="bibr">70</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">OEO was purchased from Berjé USA. 
    <br/>Chemical constituents of OEO were identified by GC–MS and consisted in: 
    <br/>thymol (65.84%), 
    <br/>p-cymene (9.86%), 
    <br/>
    <i>γ</i>-terpinene (6.73%) 
    <br/>Tested concentrations of OEO were: 5, 10, 25, 50 and 100 μg/mL. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">human stomach cancer (AGS)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Antiproliferative property of OEO in AGS was determined by MTT assay. 
    <br/>Cancer cells were incubated for 48 h with OEO. 
    <br/>IC 
    <sub>50</sub> = 13.4 μg/mL 
    <br/>The best antiproliferative activity of OEO was found to be 100 μg/mL. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B72-ijms-21-09653" ref-type="bibr">72</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Source of the material plant and chemical constituents were mentioned above in reference [ 
    <a rid="B38-ijms-21-09653" ref-type="bibr">38</a>]. 
    <br/>Tested concentrations of OEO were 50, 100, 200, 300, and 400 μg/mL 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">human breast adenocarcinoma (MCF-7) 
    <br/>cervical adenocarcinoma (HeLa) 
    <br/>T-cell lymphoblast (Jurkat) 
    <br/>colon adenocarcinoma (HT-29) 
    <br/>urinary bladder carcinoma (T24) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">In comparison to positive controls (vinblastine sulfate and taxol) OEO presented significant antitumoral activities against: 
    <br/>MCF-7 (IC 
    <sub>50</sub> = 8.11 µg/mL, taxol-IC 
    <sub>50</sub> = 0.08 µg/mL), 
    <br/>HeLa (IC 
    <sub>50</sub> = 13.41 µg/mL, vinblastine-IC 
    <sub>50</sub> = 2.5 µg/mL) 
    <br/>Jurkat (IC 
    <sub>50</sub> = 27.05 µg/mL, 
    <br/>vinblastine-IC 
    <sub>50</sub> = 0,1 µg/mL) 
    <br/>HT-29 (IC 
    <sub>50</sub> = 12.18 µg/mL, vinblastine-IC 
    <sub>50</sub> = 12.18 µg/mL) 
    <br/>T24 (IC 
    <sub>50</sub> = 105.5 µg/mL, vinblastine-IC 
    <sub>50</sub> = 63.31 µg/mL) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B38-ijms-21-09653" ref-type="bibr">38</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OEO was purchased from Edens Garden, San Clemente, CA, USA. 
    <br/>OEO was encapsulated (2.5%, 5%, 7.5%) into nanofibres of PLCL/SF polymers by electrospinning 
    <br/>Phytochemical constituents of the essential oils were not mentioned 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mammary carcinoma (mouse) 4T1 cell line</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell viability was measured by cell counting kit-8 (CCK-8) assay. 
    <br/>The incubation time for the cells on the material was 24, 48, and 72 h 
    <br/>NF membranes with 5% and 7.5% OEO contents presented a strong antiproliferative effect after 72 h 
    <br/>( 
    <i>p</i> &lt; 0,05) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B61-ijms-21-09653" ref-type="bibr">61</a>] 
   </td>
  </tr>
 </tbody>
</table>
